InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (34 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
34
T+90 hit rate
83%
T+90 mean return
+32.5%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Salzmann Peter, Chief Executive Officer. Insider active across 2 companies, notably Immunovant, Inc.. Aggregated, 41 filings have been recorded. Breakdown: 0 buy · 34 sells. Total volume traded: €11.7m. Activity tracked since 3 August 2021. The latest transaction was disclosed on 16 April 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations41 total
8,321 shares@ US$14.890.9% of flowCommon StockSEC:0001764013-25-000075:0
28,094 shares@ US$12.992.8% of flowCommon StockSEC:0001764013-25-000066:0
265,820 shares0Common StockSEC:0001764013-25-000049:0
15,439 shares@ US$20.862.6% of flowCommon StockSEC:0001764013-25-000030:0
8,352 shares@ US$23.811.6% of flowCommon StockSEC:0001764013-25-000013:0
5,105 shares@ US$24.101.0% of flowCommon StockSEC:0001764013-25-000003:0
16,692 shares@ US$25.453.4% of flowCommon StockSEC:0001764013-24-000193:0
9,095 shares@ US$28.792.1% of flowCommon StockSEC:0001764013-24-000174:0
4,460 shares@ US$29.561.0% of flowCommon StockSEC:0001764013-24-000165:0
14,470 shares@ US$31.843.5% of flowCommon StockSEC:0001764013-24-000156:0
8,175 shares@ US$29.641.9% of flowCommon StockSEC:0001764013-24-000133:0
4,619 shares@ US$28.061.0% of flowCommon StockSEC:0001764013-24-000125:0
2,783 shares0Common Stock, par value $0.0001 per shareSEC:0000950170-24-068030:0
16,163 shares@ US$29.653.8% of flowCommon StockSEC:0001764013-24-000098:0
26,365 shares@ US$28.806.1% of flowCommon StockSEC:0001764013-24-000075:0
4,807 shares@ US$31.181.2% of flowCommon StockSEC:0001764013-24-000069:0
160,534 shares0Common StockSEC:0001764013-24-000044:0
13,454 shares@ US$36.153.8% of flowCommon StockSEC:0001764013-24-000037:0
3,824 shares@ US$38.591.2% of flowCommon StockSEC:0001764013-24-000006:0
15,601 shares@ US$32.754.0% of flowCommon StockSEC:0001764013-23-000146:0
894 shares@ US$35.540.3% of flowCommon StockSEC:0001764013-23-000117:0
50,866 shares@ US$21.978.7% of flowCommon StockSEC:0001764013-23-000107:0
91,744 shares@ US$21.3415.3% of flowCommon StockSEC:0001764013-23-000094:0
101,339 shares@ US$21.7317.1% of flowCommon StockSEC:0001764013-23-000087:0
3,233 shares@ US$19.730.5% of flowCommon StockSEC:0001764013-23-000078:0
25 of 41 declarations
About Salzmann Peter
Peter Salzmann is the Chief Executive Officer of Immunovant, Inc. He leads the company with a focus on innovation and the development of new treatments. With significant experience in the biopharmaceutical sector, Peter Salzmann contributes to operational optimization and company growth. His leadership is essential for achieving strategic objectives at Immunovant.
